<?xml version="1.0" encoding="UTF-8"?>
<p xmlns="http://www.w3.org/1999/xhtml">
 <p> Mechanism of action of various non-curcuminoids anticancer pathways: ( A) Ar-turmerone; ( B) β-elemene; ( C) furanodiene; ( D) furanodinone; ( E) curcumol; ( F) calebin A; ( G) germacrone; ( H) bisacurone; and ( I) curdione. Abbreviations: ACLY, ATP citrate lyase; Akt, protein kinase B, AMPK, adenosine monophosphate–activated protein kinase; Apaf, apoptotic protease activating factor; Ar–turmerone, aromatic turmerone; ATP, adenosine triphosphate; Bax, Bcl 2 associated X protein; Bcl, B cell lymphoma 2; cdc, cell division cycle; CDKI, cyclin–dependent kinases inhibitors; CHK2, checkpoint kinase 2; COX–2, cyclooxygenase –2; DNA, deoxyribonucleic acid; DR4, death receptor4; ERK, extracellular regulated kinase; FAS, first apoptosis signal; GSK, 3–glycogen synthase kinase; γH2AX, phosphorylation of H2A histone family member X on serine 139; Her 2, human epithelial growth factor receptor 2; JNK, c Jun N terminal kinase; NF–κB, nuclear factor kappa light chain enhancer of activated B cells; Parp, poly (ADP–ribose) polymerase; PKC, protein kinase C; PI3K, phosphoinositide 3-kinase; PUMA, p 53 up regulated modulator of apoptosis; ROS, reactive oxygen species; Smac, second mitochondria-derived activator of caspases; TNF, tumor necrosis factor; TPA, 12–O–tetradecanoylphorbol–13–acetate; VCAM, vascular cell adhesion molecules; Xiap, X-linked inhibitor of apoptosis protein. </p>
 <p/>
 <p>Figure 3</p>
</p>
